Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Share News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
840.00    4.50 (0.54%)
Bid:
842.00
Ask:
845.50
Spread: 3.50 (0.416%)
Market Cap: £957.10m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Fevertree makes 'solid start' to year, reiterates FY guidance

Thu, 19th May 2022 09:57

(Sharecast News) - Drinks maker Fevertree said on Thursday that it has made "a solid start to the year", with year-to-date trading in-line with internal expectations.

Fevertree said in the UK, its most mature market, on-trade sales were impacted by the Covid-19 omicron variant at the start of the year but stated it has since seen momentum continue to build month-on-month. In the US, as well as key European and rest of the world markets, Fevertree saw strong on-trade sales that were already "well above pre-pandemic levels".

"As we look ahead to the summer months our brand strength, growing presence, and the close relationships we have built with our partners puts us in a strong position to take advantage of the consumer appetite to return to social occasions out of home," said Fevertree.

The AIM-listed firm said its UK off-trade performance has continued to rebalance in the first few months of the year as its on-trade re-emerges but said it remains "well placed" as Britain heads towards summer. Outside of Britain, Fevertree said it continued to perform well in the off-trade.

Looking forward, Fevertree noted that it continued to operate against "an industry-wide backdrop of logistics disruption" and inflationary cost pressures.

"Whilst uncertainty remains in the near-term, we are working with our supply chain partners on a large number of initiatives, including the ramping up of US East Coast production, which will help to mitigate these cost pressures as we progress further through this year and more so as we progress into 2023," said Fevertree.

"Against this backdrop, our team remains focused on supplying our customers and maintaining our strong top-line growth. We are not only confident in the long-term prospects for the brand, but also of delivering another good performance this year."

Fevertree reiterated its revenue guidance of £355.0m-£365.0m and underlying earnings guidance of £63.0m-£66.0m.

As of 1035 BST, Fevertree shares were down 0.53% at 1,515.0p.

Reporting by Iain Gilbert at Sharecast.com

Related News

UK's FTSE 100 hits over three-week low as banks, energy stocks sag
9 Jun 2026

UK's FTSE 100 hits over three-week low as banks, energy stocks sag

June 9 (Reuters) - Britain's ​blue-chip FTSE ⁠100 hit its lowest since mid-May ​on Tuesday, bogged down by losses in heavyweight lenders HSBC and Stan...

Fevertree Drinks extends share buyback after solid start to year
9 Jun 2026

Fevertree Drinks extends share buyback after solid start to year

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of ...

Fever-Tree toasts strong start to the year, shares fizz
9 Jun 2026

Fever-Tree toasts strong start to the year, shares fizz

(Sharecast News) - Shares in Fever-Tree Drinks fizzed on Tuesday, after the British business reaffirmed its full-year outlook and extended its share b...

Fevertree News

UK's FTSE 100 hits over three-week low as banks, energy stocks sag
9 Jun 2026

UK's FTSE 100 hits over three-week low as banks, energy stocks sag

June 9 (Reuters) - Britain's ​blue-chip FTSE ⁠100 hit its lowest since mid-May ​on Tuesday, bogged down by losses in heavyweight lenders HSBC and Stan...

Fevertree Drinks extends share buyback after solid start to year
9 Jun 2026

Fevertree Drinks extends share buyback after solid start to year

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of ...

Fever-Tree toasts strong start to the year, shares fizz
9 Jun 2026

Fever-Tree toasts strong start to the year, shares fizz

(Sharecast News) - Shares in Fever-Tree Drinks fizzed on Tuesday, after the British business reaffirmed its full-year outlook and extended its share b...

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...

LONDON BROKER RATINGS: Bernstein cuts Wizz Air and easyJet
13 Apr 2026

LONDON BROKER RATINGS: Bernstein cuts Wizz Air and easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

LONDON BROKER RATINGS: Goldman Sachs raises Land Securities to 'buy'
30 Mar 2026

LONDON BROKER RATINGS: Goldman Sachs raises Land Securities to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: